These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 27143082

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W, Elsiesy H, Bendahmash A, Al-Masri N, Ali S, Allam N, Al Sofayan M, Al Bahili H, Al Sebayel M, Broering D, Saab S, Abaalkhail F.
    World J Gastroenterol; 2015 Jul 14; 21(26):8140-7. PubMed ID: 26185387
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. De novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
    Xi ZF, Xia Q, Zhang JJ, Chen XS, Han LZ, Zhu JJ, Wang SY, Qiu DK.
    J Dig Dis; 2013 Aug 14; 14(8):439-45. PubMed ID: 23638710
    [Abstract] [Full Text] [Related]

  • 5. Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation.
    Cholongitas E, Goulis I, Antoniadis N, Fouzas I, Imvrios G, Giakoustidis D, Giouleme O, Papanikolaou V, Akriviadis E, Vasiliadis T.
    Transpl Infect Dis; 2016 Oct 14; 18(5):667-673. PubMed ID: 27421122
    [Abstract] [Full Text] [Related]

  • 6. Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.
    Akyildiz M, Karasu Z, Zeytunlu M, Aydin U, Ozacar T, Kilic M.
    J Gastroenterol Hepatol; 2007 Dec 14; 22(12):2130-4. PubMed ID: 18031370
    [Abstract] [Full Text] [Related]

  • 7. High prevalence of hepatitis B-antibody loss and a case report of de novo hepatitis B virus infection in a child after living-donor liver transplantation.
    Sintusek P, Posuwan N, Wanawongsawad P, Jitraruch S, Poovorawan Y, Chongsrisawat V.
    World J Gastroenterol; 2018 Feb 14; 24(6):752-762. PubMed ID: 29456414
    [Abstract] [Full Text] [Related]

  • 8. Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine.
    Jain A, Orloff M, Abt P, Kashyap R, Mohanka R, Lansing K, Kelley M, Bozorgzadeh A.
    Transplant Proc; 2005 Sep 14; 37(7):3187-9. PubMed ID: 16213345
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Liver transplantation in patients with hepatitis B virus, hepatitis C virus, or human immunodeficiency virus].
    Duclos-Vallée JC, Roche B, Samuel D.
    Presse Med; 2009 Sep 14; 38(9):1281-9. PubMed ID: 19574023
    [Abstract] [Full Text] [Related]

  • 13. Antiviral treatment for hepatitis B virus recurrence following liver transplantation.
    Lee S, Kwon CH, Moon HH, Kim TS, Roh Y, Song S, Shin M, Kim JM, Park JB, Kim SJ, Joh JW, Lee SK.
    Clin Transplant; 2013 Sep 14; 27(5):E597-604. PubMed ID: 24093615
    [Abstract] [Full Text] [Related]

  • 14. Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression.
    Lenci I, Baiocchi L, Tariciotti L, Di Paolo D, Milana M, Santopaolo F, Manzia TM, Toti L, Svicher V, Tisone G, Perno CF, Angelico M.
    Liver Transpl; 2016 Sep 14; 22(9):1205-13. PubMed ID: 27272189
    [Abstract] [Full Text] [Related]

  • 15. Prophylaxis of hepatitis B recurrence in post-liver transplantation patients with lamivudine-resistant YMDD mutant.
    Yang Y, Zhang Q, Cai CJ, Lu MQ, Li X, Jiang N, Jiang H, Xu C, Li H, Wang GS, Yi SH, Zhang J, Zhang JF, Yi HM, Zhang YC, Chen GH.
    Chin Med J (Engl); 2007 Aug 20; 120(16):1400-3. PubMed ID: 17825167
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only.
    Karlas T, Hartmann J, Weimann A, Maier M, Bartels M, Jonas S, Mössner J, Berg T, Tillmann HL, Wiegand J.
    Transpl Infect Dis; 2011 Jun 20; 13(3):299-302. PubMed ID: 21159112
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis C virus infection in Italian patients with hypogammaglobulinemia.
    Quinti I, Pandolfi F, Paganelli R, Giovannetti A, Sacco G, Oliva A, Aiuti F.
    Clin Ther; 1996 Jun 20; 18 Suppl B():96-107. PubMed ID: 8930447
    [Abstract] [Full Text] [Related]

  • 19. NIH consensus development statement on management of hepatitis B.
    Belongia EA, Costa J, Gareen IF, Grem JL, Inadomi JM, Kern ER, McHugh JA, Petersen GM, Rein MF, Sorrell MF, Strader DB, Trotter HT.
    NIH Consens State Sci Statements; 1996 Jun 20; 25(2):1-29. PubMed ID: 18949020
    [Abstract] [Full Text] [Related]

  • 20. HCV infection in patients with primary defects of immunoglobulin production.
    Quinti I, Pandolfi F, Paganelli R, el Salman D, Giovannetti A, Rosso R, Oliva A, Rainaldi L, Aiuti F.
    Clin Exp Immunol; 1995 Oct 20; 102(1):11-6. PubMed ID: 7554376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.